Investor · New York, NY

Adam E. Graev

Open Adam in the network graph →

Filings

26

SEC Form D

Connections

135

co-filers

Capital

$11.3B

across filings

Active

Mar 2020

to Sep 2023

Most-connected co-filers (135)

Josh E. Glaser · New York, NY25 shared Zamyra E. Cammans · Luxembourg, Luxembourg24 shared Gordon E. Fitzjohn · Luxembourg, Luxembourg22 shared Michael Hagen · Lehi, UT21 shared Robert Go · Boston, MA21 shared Alistair C. Smith · London, United Kingdom21 shared Carlo Pirzio-Biroli · London, United Kingdom21 shared Chi C. Cheung · London, United Kingdom21 shared Zach N. Samet · Houston, TX21 shared Joel Gamoran · Seattle, WA21 shared Deirdre E. Davies · London, United Kingdom21 shared Alan E. Turner · George Town, Grand Cayman, Cayman Islands20 shared Glendower Capital, LLP · London, United Kingdom18 shared Brad Hagen · Lehi, UT17 shared Tyler Jennings · Lehi, UT17 shared David Seeburger · Houston, TX17 shared Elizabeth Glendower Capital (Corporate Member) LTD · London, United Kingdom17 shared Brian M. Sterz · Beverly Hills, CA17 shared Lee Hower · San Francisco, CA17 shared Jeremy N. Roberts · Houston, TX17 shared Glendower Capital Sof V (Gpco.) S.A R.L · Luxembourg, Luxembourg13 shared Robert Stallone · Hawthorne, NY11 shared Brian M. Allingham · MINNEAPOLIS, MN11 shared Sean M. Stevens · MINNEAPOLIS, MN11 shared

Recent filings (26)

Glendower Capital Strategic Partnership V-1 (Nevelson), SCSpSep 2023 · 42 co-filers Glendower Capital Strategic Partnership (Albers), SCSpApr 2023 · 42 co-filers Glendower Capital Secondary Opportunities Fund V, SCSpFeb 2023 · 42 co-filers Glendower Capital Secondary Opportunities Fund V-P, LPFeb 2023 · 42 co-filers Glendower Capital SOF V (Feeder A), SCSpFeb 2023 · 42 co-filers Glendower Capital Secondary Opportunities Fund V-P(E), SCSpAug 2022 · 39 co-filers Adamis Pharmaceuticals CorpJul 2022 · 17 co-filers$300K Glendower Capital Secondary Opportunities Overage Fund II, SCSpJun 2022 · 39 co-filers Glendower Capital SOOF II (Feeder A), SCSpJun 2022 · 39 co-filers Glendower Capital Secondary Opportunities Fund V-P, LPFeb 2022 · 39 co-filers Glendower Capital Secondary Opportunities Fund V, SCSpFeb 2022 · 39 co-filers Glendower Capital SOF V (Feeder A), SCSpFeb 2022 · 39 co-filers Glendower Capital Strategic Partnership 2021 (B), LPSep 2021 · 30 co-filers Glendower Capital Secondary Opportunities Fund V-P(E), SCSpAug 2021 · 34 co-filers Glendower Capital Strategic Partnership A, SCSpJun 2021 · 35 co-filers Glendower Capital Secondary Opportunities Overage Fund II, SCSpJun 2021 · 34 co-filers Glendower Capital SOOF II (Feeder A), SCSpJun 2021 · 34 co-filers Advantage Health Properties, L.L.C.Apr 2021 · 14 co-filers$5.0M Glendower Capital Secondary Opportunities Fund V-P, LPFeb 2021 · 34 co-filers Glendower Capital Secondary Opportunities Fund V-P, LPFeb 2021 · 34 co-filers Glendower Capital Secondary Opportunities Fund V-P, LPFeb 2021 · 34 co-filers Glendower Capital Secondary Opportunities Fund V, SCSpFeb 2021 · 34 co-filers Glendower Capital SOF V (Feeder A), SCSpFeb 2021 · 30 co-filers Adamis Pharmaceuticals CorpJun 2020 · 23 co-filers$590K Advantage Health Properties, L.L.C.Mar 2020 · 14 co-filers$5.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Adam in the interactive graph →